Company Filing History:
Years Active: 2015-2016
Title: Inventor Spotlight: Sebastien Jerome Pierre
Introduction
Sebastien Jerome Pierre, an innovative inventor based in Maastricht, Netherlands, has made notable contributions to the field of pharmaceuticals. With an impressive portfolio of two patents, he specializes in the development of advanced polymer compositions that hold promise for various applications in drug delivery and formulation.
Latest Patents
Sebastien's latest patents focus on pharmaceutical compositions containing functionalized triblock copolymers. These are amphiphilic triblock copolymers characterized by a linear poly(ethylene glycol) block, which has a number average molecular weight ranging from 900 to 3000 Daltons. The hydrophobic blocks consist of cyclic monomers, including glycolide, lactide, and several others, with a specified number average molecular weight between 400 and 2000 Daltons. Importantly, these polymers feature hydroxyl end-groups that can be covalently modified with derivatives of C-C fatty acids, thereby enhancing their functionality. The inventions also highlight compositions that utilize these polymers and the potential applications of such developments.
Career Highlights
As a member of Ingell Technologies Holding B.V., Sebastien plays a pivotal role in advancing innovative solutions within the pharmaceutical industry. His exceptional ability to bridge the gap between research and practical application has garnered attention and respect from peers and industry stakeholders alike.
Collaborations
In his innovative journey, Sebastien collaborates closely with his coworker, Mike De Leeuw. Together, they synergize their expertise to explore new frontiers in biomaterials and drug formulation, paving the way for groundbreaking advancements in their field.
Conclusion
Sebastien Jerome Pierre exemplifies the spirit of innovation that drives progress in pharmaceutical sciences. Through his inventive work and collaboration with other talented professionals, he continues to inspire the next generation of inventors and researchers, making a significant impact on health and medicine. With his two patents, Sebastien is poised to remain a key figure in the evolution of pharmacological technologies.